Hostname: page-component-78c5997874-j824f Total loading time: 0 Render date: 2024-11-02T20:20:47.077Z Has data issue: false hasContentIssue false
  • English
  • Français

Neuroimaging Research and Neurocircuitry Models of Obsessive-Compulsive Disorder: Proceedings of the Third IOCDC

Published online by Cambridge University Press:  07 November 2014

Scott L. Rauch ,
Chawki Benkelfat ,
Stephen R. Dager ,
Benjamin D. Greenberg ,
Talma Hendler ,
Eric Hollander ,
Marc Laruelle ,
David R. Rosenberg ,
Sanjaya Saxena  and
Joseph Zohar
...Show all authors
Get access Rights & Permissions [Opens in a new window]

Abstract

A summary of the Third International Obsessive Compulsive Disorder Conference proceedings on neuroimaging research and neurocircuitry models of obsessive-compulsive disorder (OCD) is presented. This survey of recent and ongoing research indicates that a wide range of modern techniques and experimental strategies are being employed in a complementary fashion to enhance our understanding of OCD. Imaging studies in animal models of OCD are helping to elaborate relevant normal anatomy and neuro-chemistry. Functional imaging methods are being employed in conjunction with behavioral, pharmacologic, and cognitive challenge paradigms. Magnetic resonance spectroscopy as well as radiotracer methods are being utilized to measure neurochemical and neuropharmacologic indices in OCD. Transcranial magnetic stimulation has emerged as a tool for probing neurocircuitry that may also have therapeutic potential. Experimental designs and data-analytic methods are evolving to help elucidate the pathophysiology of OCD and related disorders, delineate neurobiologically meaningful subtypes of OCD, and identify potential predictors of treatment response. Collectively, these efforts promise important advances as we approach the new millennium.

Type
Academic Supplement Monograph
Information
CNS Spectrums , Volume 4 , supplement S3: The Third International Obsessive-Compulsive Disorder Conference , May 1999 , pp. 25 - 34
Copyright
Copyright © Cambridge University Press 1999

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

1.Baxter, LR. Functional imaging of brain systems mediating obsessive-compulsive disorder. In: Charney, D, Nestler, E, Bunney, , eds. Neurobiological Foundation of Mental Illness. New York, NY: Oxford University Press. In press.Google Scholar
2.El Mansari, M, Bouchard, C, Blier, P. Alteration of serotonin release in the guinea pig orbito-frontal cortex by selective serotonin reuptake inhibitors. Neuropsychopharmacology. 1995;13:117–127.CrossRefGoogle ScholarPubMed
3.Saxena, S, Brody, AL, Schwartz, JM, Baxter, LR. Neuroimaging and frontal-subcortical circuitry in obsessive-compulsive disorder. Br J Psychiatry. 1998;173(suppl 35):26–38.CrossRefGoogle Scholar
4.Saxena, S, Brody, AL, Maidment, KM, et al. Localized orbitofrontal and subcortical metabolic changes and prediction of response to paroxetine treatment of obsessive-compulsive disorder. Paper presented at: Third International Obsessive-Compulsive Disorder Conference Proceedings; September 11, 1998. Madeira, Portugal.Google Scholar
5.Baxter, LR, Saxena, S, Brody, AL, et al.Brain mediation of obsessive-compulsive disorder symptoms: evidence from functional brain imaging studies in the human and non-human primate. Sem Clin Neuropsychiatry. 1996;1:32–47.Google Scholar
6.Brody, AL, Saxena, S, Schwartz, JM, et al.FDG-PET predictors of response to behavioral therapy versus pharmacotherapy in obsessive-compulsive disorder. Psychiatry Research: Neuroimaging. 1998;84:1–6.CrossRefGoogle Scholar
7.McDougle, CJ, Fleischmann, RL, Epperson, CN, et al.Risperidone addition in fluvoxamine-refractory obsessive-compulsive disorder: three cases. J Clin Psychiatry. 1995;56:526–528.Google ScholarPubMed
8.Saxena, S, Wang, D, Bystritsky, A, Baxter, LR. Risperidone augmentation of SRI treatment for refractory obsessive-compulsive disorder. J Clin Psychiatry. 1996;57(7):303–306.Google ScholarPubMed
9.Ravizza, L, Barzega, G, Bellino, S, Bogetto, F, Maina, G. Therapeutic effect and safety of adjunctive risperidone in refractory obsessive-compulsive disorder. Psychopharmacol Bull. 1996;32(4):677–682.Google ScholarPubMed
10.Zohar, J, Insel, T, Berman, K, et al.Anxiety and cerebral blood flow during behavioral challenge: dissociation of central from peripheral and subjective measures. Arch Gen Psychiatry. 1989;46:505–510.CrossRefGoogle ScholarPubMed
11.Rauch, SL, Jenike, MA, Alpert, NM, et al.Regional cerebral blood flow measured during symptom provocation in obsessive-compulsive disorder using 150-labeled CO2 and positron emission tomography. Arch Gen Psychiatry. 1994;51:62–70.CrossRefGoogle Scholar
12.McGuire, PK, Bench, CJ, Frith, CD, et al.Functional anatomy of obsessive-compulsive phenomena. Br J Psychiatry. 1994;164:459–468.CrossRefGoogle ScholarPubMed
13.Breiter, HC, Rauch, SL, Kwong, KK, et al.Functional magnetic resonance imaging of symptom provocation in obsessive compulsive disorder. Arch Gen Psychiatry. 1996;53:595–606.CrossRefGoogle ScholarPubMed
14.Hollander, E, Prohovnik, I, Stein, DJ. Increased cerebral blood flow during m-CPP exacerbation of obsessive-compulsive disorder. J Neuropsychiatry. 1995;7:485–490.Google ScholarPubMed
15.Rauch, SL, Baxter, LR. Neuroimaging of OCD and related disorders. In: Jenike, MA, Baer, L, Minichiello, WE, eds. Obsessive-Compulsive Disorders: Practical Management. Boston, Mass: Mosby; 1998:289–317.Google Scholar
16.Rauch, SL, Whalen, PJ, Dougherty, DD, Jenike, MA. Neurobiological models of obsessive compulsive disorders. In: Jenike, MA, Baer, L, Minichiello, WE, eds. Obsessive-Compulsive Disorders: Practical Management. Boston, Mass: Mosby; 1998:222–253.Google Scholar
17.Rauch, SL, Savage, CR, Brown, HD, et al.A PET investigation of implicit and explicit sequence learning. Human Brain Mapping. 1995;3:271–286.CrossRefGoogle Scholar
18.Doyon, J, Owen, AM, Petrides, M, et al.Functional anatomy of visuomotor skill learning in human subjects examined with positron emission tomography. Eur J Neurosci. 1996;8:637–648.CrossRefGoogle ScholarPubMed
19.Rauch, SL, Savage, CR, Alpert, NM, et al.Probing striatal function in obsessive compulsive disorder: a PET study of implicit sequence learning. J Neuropsychiatry. 1997;9:568–573.Google ScholarPubMed
20.Rauch, SL, Whalen, PJ, Savage, CR, et al.Striatal recruitment during an implicit sequence learning task as measured by functional magnetic resonance imaging. Human Brain Mapping. 1997;5:124–132.3.0.CO;2-5>CrossRefGoogle ScholarPubMed
21.Rauch, SL, Whalen, PJ, Curran, T, Mclnerney, S, Savage, CR. Thalamic deactivation during early implicit sequence learning: a functional MRI study. Neuroreport. 1998;9:865–870.CrossRefGoogle ScholarPubMed
22.Szabo, Z, Kao, PF, Scheffel, U, et al.Positron emission tomography imaging of serotonin transporters in the human brain using [11C](+)McN5652. Synapse. 1995;20:37–43.CrossRefGoogle ScholarPubMed
23.Pike, VW, McCarron, JA, Lammerstma, AA, et al.Exquisite delineation of 5-HT1A receptors in human brain with PET and [carbonyl-11C]WAY-100635. Eur J Pharmacol. 1996;301:R5–R7.CrossRefGoogle ScholarPubMed
24.Ito, H, Nyberg, S, Halldin, C, Lundvist, C, Farde, L. PET imaging of central 5-HT2A receptors with carbon-11-MDL 100,907. J Nucl Med. 1998;39:208–214.Google ScholarPubMed
25.Laruelle, M, Baldwin, RM, Malison, RT, et al.SPECT imaging of dopamine and serotonin transporters with [123I]ß-CIT: pharmacological characterization of brain uptake in nonhuman primates. Synapse. 1993;13:295–309.CrossRefGoogle Scholar
26.Abi-Dargham, A, Zea-Ponce, Y, Terriere, D, et al.Preclinical evaluation of [I-123]R93274 as a SPECT radiotracer for imaging serotonin 5-HT2A receptors. Eur J Pharmacol. 1997;321:285–293.CrossRefGoogle Scholar
27.Talairach, J, Tournoux, P. Co-Planar Stereotaxic Atlas of the Human Brain. New York, NY: Thieme Medical Publishers, Inc; 1988.Google Scholar
28.Dager, SR, Steen, RG. Applications of magnetic resonance spectroscopy to the investigation of neuropsychiatric disorders. Neuropsychopharmacology. 1992;6(4):249–266.Google Scholar
29.Strauss, W, Layton, M, Hayes, C, Dager, SR. 19F-MRS investigation in vivo of acute and steady-state brain fluvoxamine levels in obsessive-compulsive disorder. Am J Psychiatry. 1997;154(4):516–522.Google Scholar
30.Strauss, W, Layton, M, Dager, SR. Brain elimination half-life of fluvoxamine measured by 19F magnetic resonance spectroscopy. Am J Psychiatry. 1998;155(3):380–384.CrossRefGoogle ScholarPubMed
31.Moore, GJ, MacMaster, FP, Stewart, C, Rosenberg, DR. Case study: caudate glutamatergic changes with paroxetine therapy for pediatric obsessive compulsive disorder. J Am Acad Child Adolesc Psychiatry. 1998;27(6):663–667.CrossRefGoogle Scholar
32.Greenberg, BD, George, MS, Martin, JD, et al.Effect of prefrontal repetitive transcranial magnetic stimulation in obsessive-compulsive disorder: a preliminary study. Am J Psychiatry. 1997;154:867–869.Google ScholarPubMed
33.Ziemann, U, Paulus, W, Rothenberger, A. Decreased motor inhibition in Tourette's disorder: evidence from transcranial magnetic stimulation. Am J Psychiatry. 1997;154:1277–1284.Google ScholarPubMed
34.Greenberg, BD, Ziemann, U, Harmon, A, Murphy, DL, Wassermann, EM. Reduced intracortical inhibition in obsessive-compulsive disorder on transcranial magnetic stimulation. Lancet. 1998;352:881–882.CrossRefGoogle Scholar
35.Leckman, JF, Peterson, BS, Pauls, DL, Cohen, DJ. Tic disorders. Psychiatr Clin North Am. 1997;20(4): 839–862.CrossRefGoogle ScholarPubMed
36.Ziemann, U, Lonnecker, S, Steinhoff, BJ, Paulus, W. Effects of antiepileptic drugs on motor cortex excitability in humans: a transcranial magnetic stimulation study. Ann Neurology. 1996;40(3):367–378.CrossRefGoogle ScholarPubMed
37.Corá-Locatelli, G, Greenberg, BD, Martin, JD, Leong, YM, Murphy, DL. Gabapentin augmentation for fluoxetine-treated patients with obsessive-compulsive disorder [letter]. J Clin Psychiatry. 1998;59:480–481.CrossRefGoogle ScholarPubMed
38.Corá-Locatelli, G, Greenberg, BD, Martin, JD, Murphy, DL. Rebound psychiatric and physical symptoms after gabapentin discontinuation [letter]. J Clin Psychiatry. 1998;59:131.CrossRefGoogle ScholarPubMed